The quarter fell well short of published expectations. Consensus estimates were roughly $5.8–$6.1 million of revenue and a $0.29 per-share loss; PureCycle delivered $4.5 million and a $0.80 loss. The EPS miss was amplified by a $52.5 million warrant revaluation and a $34.5 million debt-extinguishment charge, but even the underlying operating result was still a $41.3 million loss. (Income Statement; Adjusted EBITDA reconciliation)
| Metric | Q2 2026 | Comparison / expectation |
|---|---|---|
| Revenue | $4.5M | $1.7M Q2 2025; published consensus roughly $5.8M–$6.1M |
| EPS | $(0.80) | $(0.81) Q2 2025; consensus $(0.29) |
| Operating loss | $(41.3)M | $(45.6)M Q2 2025 |
| Adjusted EBITDA | $(31.7)M | $(27.8)M Q2 2025 |
| PureFive production | 4.5M lbs | 8.4M lbs Q1 2026; 3.4M lbs Q2 2025 |
| Monthly operations spending | $8.3M | $8.5M Q1 2026; $9.0M Q2 2025 |
| FY2026 project-spend outlook | $45M–$50M | Previously $39M–$45M |
| Total liquidity | $236.9M | $131M at Q1 2026 |
The commercial story did improve, but not yet enough to offset the miss. First P&G commercial resin deliveries began, seven customer conversions were added, on-site compounding reached roughly 2.0 million pounds, and New Jersey approved PureFive as post-consumer recycled content. (Second Quarter 2026 Highlights — Commercial; Operations) Those are meaningful proof points for customer qualification, but Q2 revenue remained below expectations and production fell sequentially because of the planned turnaround. The filing therefore shows progress toward adoption, not a demonstrated high-volume ramp.
The balance sheet is stronger, but the improvement was bought with capital rather than operations. Liquidity rose to $236.9 million after concurrent stock and convertible-note offerings, while the company also repurchased $216.0 million of older convertible debt. (Cash and Liquidity; Capital Structure) Six-month operating cash burn was $92.7 million, and the higher $45 million–$50 million project-spend outlook adds to funding needs. (Cash Flow statement; Project Spend) The financing reduces near-term liquidity pressure but brings meaningful dilution and does not resolve the negative cash-generation profile.
Net, the filing is negative versus expectations despite better execution evidence. Revenue and GAAP EPS missed materially, adjusted EBITDA worsened year over year, and planned spending increased. The commercial milestones and lower core operating spend improve the longer-term credibility of the platform, but this quarter does not confirm the near-term revenue ramp the market was expecting.
Read the original 8-K on SEC EDGAR ↗